Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
284,3 USD | -0,69% | +2,66% | -1,28% |
09/03 | Amgen presenteert nieuw onderzoek naar Otezla (apremilast) op AAD 2024 | CI |
08/03 | ETF van de week: inzetten op de ommekeer in de biotech |
Omzet 2024 * | 33,01 mld. 30,63 mld. | Omzet 2025 * | 34,06 mld. 31,6 mld. | Marktkapitalisatie | 152 mld. 141 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 6,13 mld. 5,68 mld. | Nettowinst (verlies) 2025 * | 7,57 mld. 7,02 mld. | EV/omzet 2024 * | 6,03 x |
Nettoschuld 2024 * | 46,57 mld. 43,21 mld. | Nettoschuld 2025 * | 40,77 mld. 37,83 mld. | EV/omzet 2025 * | 5,67 x |
K/w-verhouding 2024 * |
24,6
x | K/w-verhouding 2025 * |
19,1
x | Werknemers | 26.700 |
Dividendrendement 2024 * |
3,25% | Dividendrendement 2025 * |
3,52% | Vrij verhandelbaar | 99,75% |
Recentste transcriptie over Amgen Inc.
1 dag | -0,69% | ||
1 week | +2,66% | ||
Lopende maand | +3,83% | ||
1 maand | +2,47% | ||
3 maanden | -1,44% | ||
6 maanden | +4,98% | ||
Lopend jaar | -1,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 61 | 01-06-06 |
Peter Griffith
DFI | Director of Finance/CFO | 65 | 23-10-19 |
Chief Tech/Sci/R&D Officer | 53 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Charles Holley
BRD | Director/Board Member | 67 | 03-02-17 |
Ellen Kullman
BRD | Director/Board Member | 68 | 14-10-16 |
Robert Williams
BRD | Director/Board Member | 75 | 17-10-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
7.84% | 0 M€ | 0,00% | - | |
7.63% | 0 M€ | 0,00% | - | |
5.08% | 108 M€ | +13,09% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 284,3 | -0,69% | 2 289 919 |
27-03-24 | 286,3 | +1,61% | 2 256 315 |
26-03-24 | 281,8 | +0,34% | 3 343 181 |
25-03-24 | 280,8 | +1,68% | 2 954 416 |
22-03-24 | 276,2 | -0,28% | 2 303 249 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,28% | 152 mld. | |
+33,46% | 701 mld. | |
+26,24% | 570 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 322 mld. | |
+0,74% | 209 mld. | |
+2,95% | 212 mld. | |
-6,05% | 205 mld. | |
-3,61% | 157 mld. |